Trial Profile
Effect of Teriflunomide on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective Observational Case-control Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2021
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 04 Jan 2021 Status changed from active, no longer recruiting to completed.
- 10 Oct 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 18 May 2018 New trial record